MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-01-0018420
Vitthal Drugs Pvt Ltd
Vitthal Drugs Pvt Ltd - transport and logistics in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹98.37 Lakh
▲ 4% YoY
Net profit · FY 2025
₹18.27 Lakh
Net margin 18.6%
EBITDA · FY 2025
₹28.76 Lakh
EBITDA margin 29.2%
Authorised capital
₹14.5 Lakh
Registered with MCA
Paid-up capital
₹14.5 Lakh
Issued & subscribed
Open charges
₹9 Lakh
Satisfied ₹40 Lakh
Company age
43 yrs
Est. 1983
Directors on board
2
As per MCA filings
About Vitthal Drugs Pvt Ltd
Data last updated:
Vitthal Drugs Pvt Ltd is a private limited company based in Delhi, India. It operates in the carrying and forwarding agents (cfa) segment of the transport and logistics sector. It was incorporated on 15 October 1983 and has been in existence for over 43 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL1983PTC016771. Its GSTIN is 08AABCV5538L1ZW (Rajasthan).
The company has an authorised share capital of ₹14.5 Lakh and a paid-up capital of ₹14.5 Lakh. It is led by directors Vidyut Bhalotia and Kadambari Bhalotia.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 2862 4th Floor Bazar Sirkiwlan Hauz Qazi, Delhi, India – 110006.
As per the financials filed for FY 2025, the company reported a revenue of ₹98.37 Lakh, a growth of 4% compared to the previous year. For the same year it recorded a net profit of ₹18.27 Lakh (net margin 18.6%) and EBITDA of ₹28.76 Lakh (EBITDA margin 29.2%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years and 3% over five years.
As per MCA filings, the company has open charges of ₹9 Lakh and satisfied charges of ₹40 Lakh on record.
Vitthal Drugs Pvt Ltd is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-01-0018420). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U74899DL1983PTC016771
Registration Number 016771
Incorporation Date 15 October 1983
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-01-0018420
Recognitions & Rankings of Vitthal Drugs
Contact details
Vitthal Drugs Pvt Ltd's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address2862 4th Floor Bazar Sirkiwlan Hauz Qazi, Delhi, India – 110006
- IndustryTransport and Logistics, Carrying & Forwarding Agents (CFA)
To see the full contact details of Vitthal Drugs Pvt Ltd, buy the company report.
Comprehensive company report
Vitthal Drugs Pvt Ltd - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Vitthal Drugs is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities |
To see the full business activity and turnover split of Vitthal Drugs Pvt Ltd, buy the company report.
Financials of Vitthal Drugs Pvt Ltd
FY 2025 filings availableVitthal Drugs Pvt Ltd reported revenue of ₹98.37 Lakh (up 4% YoY) for FY 2025.
Revenue · FY 2025
₹98.37 Lakh ▲ 4%
Net profit · FY 2025
₹18.27 Lakh margin 18.6%
EBITDA · FY 2025
₹28.76 Lakh margin 29.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 4%
3 years · compounded
▲ 8%
5 years · compounded
▲ 3%
EBITDA CAGR growth
1 year
▲ 3%
3 years · compounded
▲ 32%
5 years · compounded
▲ 6%
Revenue has grown at a compounded annual rate (CAGR) of 3% over five years, including 4% growth in the latest year. EBITDA rose 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹28.76 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹18.27 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 29.2% | ||||
| Net Profit Margin | 18.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Vitthal Drugs Pvt Ltd, buy the company report.
Board of directors of Vitthal Drugs Pvt Ltd
Vitthal Drugs has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vidyut Bhalotia Also directs: Malborough Polychem LLP | Director | 20 Dec 2018 | 7 Years 10 Months | Current |
| Kadambari Bhalotia Also directs: Malborough Polychem LLP | Director | 10 Oct 2017 | 9 Years 0 Months | Current |
Auditor
Vitthal Drugs Pvt Ltd is audited by K N GUTGUTIA & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K N GUTGUTIA & CO | FY 2019 | 304153E |
Shareholding
The shareholding of Vitthal Drugs Pvt Ltd is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Vitthal Drugs Pvt Ltd, buy the company report.
Charges & borrowings
Open charges
₹9 Lakh
Satisfied charges
₹40 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 17 Feb 2024 | 100881218 | Others | ₹9 Lakh | Open | |
| 06 Jun 2018 | 100187082 | Others | ₹25 Lakh | Satisfied | |
| 01 Jun 2001 | 80028068 | Oriental Bank of Commerce | ₹15 Lakh | Satisfied |
To see the full charge records of Vitthal Drugs Pvt Ltd, buy the company report.
Total charge records: 3 View all charges
Legal cases
No court or tribunal cases involving Vitthal Drugs Pvt Ltd are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Vitthal Drugs Pvt Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Vitthal Drugs has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AABCV5538L1ZW | Rajasthan | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Vitthal Drugs Pvt Ltd, buy the company report.
Recent activity
Vitthal Drugs Pvt Ltd has 4 board changes on record since 2017: 2 appointments and 2 cessations. The latest: Om Prakash Bhalotia ceased to be Director on 22 Dec 2018.
AGM
Vitthal Drugs Pvt Ltd last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Vitthal Drugs Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge with Others amounted to Rs. 9.00 Lakh with Charge ID 100881218 was registered on 17 Feb 2024.
Charges
A charge registered on 06 Jun 2018 via Charge ID 100187082 with Others was fully satisfied on 24 Mar 2023.
Ceased
Om Prakash Bhalotia ceased to be Director.
Appointed
Vidyut Bhalotia was appointed as Director.
Charges
A charge with Others amounted to Rs. 25.00 Lakh with Charge ID 100187082 was registered on 06 Jun 2018.
Charges
A charge registered on 01 Jun 2001 via Charge ID 80028068 with Oriental Bank Of Commerce was fully satisfied on 27 Apr 2018.
Appointed
Kadambari Bhalotia was appointed as Director.
Ceased
Vidyut Bhalotia ceased to be Director.
Charges
A charge with Oriental Bank Of Commerce of Rs. 15.00 Lakh registered on 01 Jun 2001 with Charge ID 80028068 was modified on 22 Mar 2007.
Charges
A charge with Oriental Bank Of Commerce amounted to Rs. 15.00 Lakh with Charge ID 80028068 was registered on 01 Jun 2001.
1 earlier event is in the company report.
Frequently asked questions
Vitthal Drugs is an active private limited company based in Delhi, India. The company works in carrying and forwarding agents (cfa), within the transport and logistics industry. It was incorporated on 15 October 1983 (43+ years old) and is registered under CIN U74899DL1983PTC016771.
Vitthal Drugs has 2 current directors:
- Vidyut Bhalotia - Director
- Kadambari Bhalotia - Director
The latest financial statements of Vitthal Drugs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Vitthal Drugs is 08AABCV5538L1ZW, registered in Rajasthan.
The CIN (Corporate Identification Number) of Vitthal Drugs is U74899DL1983PTC016771. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vitthal Drugs was incorporated on 15 October 1983, making it 43+ years old. It is registered with the Registrar of Companies, Delhi.
Om Prakash Bhalotia ceased to be Director on 22 Dec 2018. Vidyut Bhalotia was appointed as Director on 20 Dec 2018. Kadambari Bhalotia was appointed as Director on 10 Oct 2017. Vitthal Drugs has 4 board changes on record in total.
Yes, Vitthal Drugs is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-01-0018420).
The registered office of Vitthal Drugs is at 2862 4th Floor Bazar Sirkiwlan Hauz Qazi, Delhi, India – 110006.
Vitthal Drugs operates in the transport and logistics industry, in the carrying and forwarding agents (cfa) segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages